Cusatuzumab Chemische Eigenschaften,Einsatz,Produktion Methoden

Beschreibung

Cusatuzumab is designed as a first-in-class, high-affinity anti-CD70 monoclonal antibody with multiple intended mechanisms of action, including Fc-mediated cytotoxicity with enhanced ADCC and inhibition of CD70/CD27 signaling, resulting in killing of malignant cells such as leukemia blasts and stem cells.

Cusatuzumab Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Cusatuzumab Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
ShangHai Biochempartner Co.,Ltd	177-54423994 17754423994	2853530910@QQ.com	China	7999	62
Guangzhou Hongyuan Chemical Co.,Ltd	15817493340	981810490@qq.com	China	1566	58
Wuhan Chemstan Biotechnology Co., Ltd.	027-65317797 15926423062	422450190@qq.com	China	10308	58
Biolab Reagents	18108604356	info@biolabreagent.com	China	9868	58
Wuhan Jingkangen Biomedical Technology Co., Ltd	13720134139 086-15871494362 13720134139	orders@jknbiochem.com	China	6220	58
Shanghai Yifei Biotechnology Co. , Ltd.	021-65675885 18964387627	customer_service@efebio.com	China	11973	58
Changsha Fuzhen Biotechnology Co.，LTD	13823398779	3062105966@qq.com	China	3452	58
Atagenix Laboratories	027-87008169 17762441161	info@atagenix.com	China	9914	58
AntibodySystem Laboratories SAS	33175446423	support@antibodysystem.com	China	6739	58
Cell Sciences	9785721070	info@cellsciences.com	China	6308	58

---

• Cusatuzumab
• Research Grade Cusatuzumab(DHE01901)
• Research Grade Cusatuzumab
• 1399546-01-0